The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
Pasquale Pagliano
1
,
Carmine Sellitto
2
,
Tiziana Ascione
3
,
Giuliana Scarpati
4
,
Veronica Folliero
5
,
Ornella Piazza
4
,
Gianluigi Franci
6
,
Amelia Filippelli
2
,
Valeria Conti
2
3
Department of Medicine, Service of Infectious Diseases, Cardarelli Hospital, Naples, Italy
|
Publication type: Journal Article
Publication date: 2022-12-12
scimago Q1
wos Q1
SJR: 1.195
CiteScore: 10.6
Impact factor: 4.9
ISSN: 17460441, 1746045X
PubMed ID:
36508255
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Farmatsiya i Farmakologiya
1 publication, 5.88%
|
|
|
Expert Opinion on Drug Discovery
1 publication, 5.88%
|
|
|
Reproductive Toxicology
1 publication, 5.88%
|
|
|
Mendeleev Communications
1 publication, 5.88%
|
|
|
ACS Pharmacology & Translational Science
1 publication, 5.88%
|
|
|
Expert Opinion on Drug Metabolism and Toxicology
1 publication, 5.88%
|
|
|
Expert Opinion on Investigational Drugs
1 publication, 5.88%
|
|
|
Bioorganic Chemistry
1 publication, 5.88%
|
|
|
Russian Journal of General Chemistry
1 publication, 5.88%
|
|
|
Antiviral Research
1 publication, 5.88%
|
|
|
Molecules
1 publication, 5.88%
|
|
|
Mutation Research - Reviews in Mutation Research
1 publication, 5.88%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 5.88%
|
|
|
Toxicological Sciences
1 publication, 5.88%
|
|
|
Computers in Biology and Medicine
1 publication, 5.88%
|
|
|
Current Nutrition and Food Science
1 publication, 5.88%
|
|
|
Journal of Materials Research
1 publication, 5.88%
|
|
|
1
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 35.29%
|
|
|
Taylor & Francis
3 publications, 17.65%
|
|
|
Volgograd State Medical University
1 publication, 5.88%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 5.88%
|
|
|
American Chemical Society (ACS)
1 publication, 5.88%
|
|
|
Pleiades Publishing
1 publication, 5.88%
|
|
|
MDPI
1 publication, 5.88%
|
|
|
Oxford University Press
1 publication, 5.88%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 5.88%
|
|
|
Springer Nature
1 publication, 5.88%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
17
Total citations:
17
Citations from 2025:
6
(35.29%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Pagliano P. et al. The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 12. pp. 1-13.
GOST all authors (up to 50)
Copy
Pagliano P., Sellitto C., Ascione T., Scarpati G., Folliero V., Piazza O., Franci G., Filippelli A., Conti V. The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 12. pp. 1-13.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/17460441.2022.2153828
UR - https://doi.org/10.1080/17460441.2022.2153828
TI - The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
T2 - Expert Opinion on Drug Discovery
AU - Pagliano, Pasquale
AU - Sellitto, Carmine
AU - Ascione, Tiziana
AU - Scarpati, Giuliana
AU - Folliero, Veronica
AU - Piazza, Ornella
AU - Franci, Gianluigi
AU - Filippelli, Amelia
AU - Conti, Valeria
PY - 2022
DA - 2022/12/12
PB - Taylor & Francis
SP - 1-13
IS - 12
VL - 17
PMID - 36508255
SN - 1746-0441
SN - 1746-045X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Pagliano,
author = {Pasquale Pagliano and Carmine Sellitto and Tiziana Ascione and Giuliana Scarpati and Veronica Folliero and Ornella Piazza and Gianluigi Franci and Amelia Filippelli and Valeria Conti},
title = {The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)},
journal = {Expert Opinion on Drug Discovery},
year = {2022},
volume = {17},
publisher = {Taylor & Francis},
month = {dec},
url = {https://doi.org/10.1080/17460441.2022.2153828},
number = {12},
pages = {1--13},
doi = {10.1080/17460441.2022.2153828}
}
Cite this
MLA
Copy
Pagliano, Pasquale, et al. “The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19).” Expert Opinion on Drug Discovery, vol. 17, no. 12, Dec. 2022, pp. 1-13. https://doi.org/10.1080/17460441.2022.2153828.